Competition

  • July 14, 2025

    Media Matters Wants FTC Probe Paused Pending Suit

    Media Matters for America asked a D.C. federal court Monday for a preliminary injunction to block what it calls a retaliatory investigation by the Federal Trade Commission, saying the agency has been weaponized against the organization for simply exercising its First Amendment rights.

  • July 14, 2025

    LinkedIn Antitrust Deal Offers Open Access And $4M For Attys

    LinkedIn will stop conditioning online interface access on would-be rivals agreeing not to field their own professional social network, under an antitrust settlement with premium subscribers disclosed Friday in California federal court that promises $4 million for class attorneys from Bathaee Dunne LLP, Burke LLP and Korein Tillery PC.

  • July 14, 2025

    Google Ads Rival Wants Search Fix To Include It, AI Cos.

    If a D.C. federal judge agrees with the Justice Department and orders Google to syndicate its search and search advertising results, he should do so in a way that permits expansive access, a search advertising rival said Friday in an 11th-hour intervention bid.

  • July 14, 2025

    Microsoft, OpenAI Ask 9th Circ. To Toss Coders' DMCA Claims

    Microsoft and OpenAI have asked the Ninth Circuit to affirm the dismissal of a suit brought by coders who claim that the companies' large language models spit out code almost identical to code they wrote, saying the coders have only alleged hypothetical injuries.

  • July 14, 2025

    $94M Fee Bid In Auto Parts Antitrust MDL Rejected, For Now

    A Michigan federal judge on Friday rejected class counsel's request to add $94 million to the $269 million fee award they have already secured for cutting deals totaling $1.2 billion resolving automotive parts antitrust litigation, finding that the request is excessive and premature, but allowing counsel to revise it in the future.

  • July 14, 2025

    Tevra Asks 9th Circ. To Revive Bayer Flea, Tick Meds Suit

    Tevra Brands LLC called on the Ninth Circuit to order a new trial after it said a lower court made several errors that prevented it from showing a jury that Bayer HealthCare LLC used exclusive contracts to lock up the market for a flea and tick treatment for dogs and cats.

  • July 11, 2025

    NCAA's $2.8B NIL Deal Nets Athletes' Firms Over $455M In Fees

    A California federal judge Friday approved approximately $455 million in attorney fees for class counsel in the NCAA's $2.78 billion class action settlement that, for the first time, will provide for revenue sharing with college athletes, with additional fees set to roll in annually for 10 years.

  • July 11, 2025

    Ill. Judge Wants Limited Ethics Claim Info In Aid-Fixing Suit

    An Illinois federal judge weighing ethical fee concerns in an aid-fixing suit against several elite universities said Friday that the class attorney who raised the issue should outline his dispute in a sealed filing before the court decides whether discovery should be taken over it.

  • July 11, 2025

    Amgen Eyes New Trial After Regeneron's $407M Antitrust Win

    Amgen urged a Delaware federal judge in documents made public Friday to overturn a nearly $407 million antitrust and tortious-interference verdict in favor of Regeneron, saying there was a serious lack of evidence shown to the jury.

  • July 11, 2025

    Courts Face Early Push To Expand Justices' Injunction Ruling

    In the two weeks since the U.S. Supreme Court curtailed federal judges' ability to issue universal injunctions, Trump administration attorneys have begun pushing to expand the decision's limits to other forms of relief used in regulatory challenges and class actions. So far, judges don't appear receptive to those efforts. 

  • July 11, 2025

    NPE Drops Injunction Bid In Samsung IP Suit Eyed By Feds

    A nonpracticing entity has dropped its bid for a preliminary injunction in its patent infringement case against Samsung in eastern Texas federal court, shortly after the federal government made the rare move of expressing interest in the case.

  • July 11, 2025

    Success Tricking FDA Shouldn't Protect Merck, Justices Told

    Physicians asked the U.S. Supreme Court to review a decision immunizing Merck & Co. from antitrust claims over submissions it made to federal regulators over its mumps vaccine, arguing the Third Circuit went far beyond its peers in holding that deceiving the government isn't illegal if the deception worked.

  • July 11, 2025

    Google Won't Have To Turn Over EU Ad Tech Settlement Docs

    A Virginia federal judge refused a request from the U.S. Department of Justice Friday to force Google to hand over submissions it made to European enforcers when trying to settle their investigation as the sides ready for a remedies trial in the ad tech monopolization case.

  • July 11, 2025

    Compass Says It Will Share Exclusive Listings With Any Brokers

    Brokerage firm Compass Inc. announced Friday that it will conditionally share its exclusive homeowners listings with any brokers or multiple listing services.

  • July 11, 2025

    The Biggest TM Rulings Of 2025: A Midyear Report

    Justices overturned a trademark award of more than $40 million in a long-running case in which lower courts put a company's affiliates on the hook for the amount, and a pair of precedential decisions from the Federal Circuit provided guidance on whether colors can be protected trade dress. Here is Law360's list of the biggest trademark decisions so far this year.

  • July 11, 2025

    Merck's $10B Pulmonary Power Play Is Among Its Top 5 Deals

    When Merck agreed to purchase respiratory disease-focused Verona Pharma PLC for $10 billion, it became one of Merck's largest deals ever, and the pharmaceutical giant made clear that its bet on a potentially transformative pulmonary therapy was much more than a speculative pipeline acquisition.

  • July 11, 2025

    FCC Approves T-Mobile's $4.4B UScellular Deal

    Federal Communications Commission staff late Friday approved the license transfers needed for T-Mobile to complete its $4.4 billion acquisition of UScellular wireless operations.

  • July 11, 2025

    MSN Beats Novartis' Patent Suit Over Entresto

    A Delaware federal judge on Friday found that Novartis couldn't show that MSN Pharmaceuticals Inc. infringed a patent related to its blockbuster drug Entresto, the latest in the company's wide-ranging fight to keep a generic version of the product off the market.

  • July 11, 2025

    Suppressing Rival Views Can Break Antitrust Laws, DOJ Says

    The anti-vaccine group once tied to Secretary of Health and Human Services Robert F. Kennedy Jr. got a boost Friday in its D.C. federal court suit alleging that the Associated Press, The Washington Post, Reuters and the BBC colluded with social media platforms to censor rivals, drawing a Justice Department brief assailing news organization assertions that viewpoint competition can't be illegally suppressed.

  • July 11, 2025

    FTC Looks To Extend Pause Of Noncompete Rule Appeal

    The Federal Trade Commission has asked the Fifth Circuit to keep an appeal over the commission's blocked noncompete rule on hold for another 60 days as the agency continues to mull whether it actually wants to defend the rule.

  • July 11, 2025

    Conservative Groups Bash Idea Of Next-Gen TV Mandate

    The growing battle over potential federal rules to move the U.S. toward next-generation TV continued this week as several right-leaning groups came out swinging against government mandates forcing the switchover.

  • July 11, 2025

    Hess Faces Investor Suit Over $53B Chevron Deal

    As the parties await the result of a critical arbitration proceeding that could sink a planned $53 billion sale of Hess to Chevron, a shareholder is arguing that the deal disproportionately benefits CEO John Hess at the expense of the company's investors.

  • July 11, 2025

    Phones4u Can't Revive Collusion Case Against UK Networks

    The Court of Appeal dismissed Phones 4u's claims Friday that the U.K.'s biggest phone operators colluded to drive the retailer out of business, upholding findings that there was no evidence of anticompetitive behavior between the networks.

  • July 10, 2025

    Punitive Damages Ruling Deferred In Jack Nicklaus' Fla. Suit

    A Florida state court judge deferred a decision on whether he'll overrule a previous order denying punitive damages in a defamation lawsuit brought by former professional golfer Jack Nicklaus against a company he founded and two of its officers, saying there must be enough evidence to find that reprehensible misconduct occurred.

  • July 10, 2025

    Trump Taps Holland & Hart Partner For Montana Bench

    President Donald Trump announced on social media Thursday he has chosen a Holland & Hart LLP partner and veteran government attorney to serve on the federal bench in Montana.

Expert Analysis

  • NCAA Rulings Signal Game Change For Athlete Classification

    Author Photo

    A Tennessee federal court's recent decision in Pavia v. NCAA adds to a growing call to consider classifying college athletes as employees under federal law, a change that would have unexpected, potentially prohibitive costs for schools, says J.R. Webster Cucovatz at Gilson Daub.

  • Opinion

    NCAA Name, Image, Likeness Settlement Is A $2.8B Mistake

    Author Photo

    While the plaintiffs in House v. NCAA might call the proposed settlement on name, image and likeness payments for college athletes a breakthrough, it's a legally dubious Band-Aid that props up a system favoring a select handful of male athletes at the expense of countless others, say attorneys at Clifford Chance.

  • What FERC Scrutiny Of Directors, Assets Means For Investors

    Author Photo

    The Federal Energy Regulatory Commission has recently paid dramatically increased attention to appointments of power company directors by investors, and ownership of vertical assets that provide inputs for electric power production and sale — so investors in FERC-regulated entities should be paying more attention to these matters as well, say attorneys at Day Pitney.

  • Opinion

    Antitrust Analysis In Iowa Pathologist Case Misses The Mark

    Author Photo

    An Iowa federal court erred in its recent decision in Goldfinch Laboratory v. Iowa Pathology Associates by focusing exclusively on market impacts and sidestepping key questions that should be central to antitrust standing analysis, says Daniel Graulich at Baker McKenzie.

  • 3 Ways Civil Plaintiffs Could Fill An FCPA Enforcement Gap

    Author Photo

    While the Department of Justice recently announced it would deprioritize Foreign Corrupt Practices Act investigations into U.S. businesses without obvious ties to international crime, companies should stay alert to private plaintiffs, who could fill this enforcement void — and win significant civil damages — through several legal channels, says Eric Nitz at MoloLamken.

  • Dewberry Ruling Is A Wakeup Call For Trademark Owners

    Author Photo

    The U.S. Supreme Court's decision in Dewberry v. Dewberry hones in on the question of how a defendant's affiliates' profits should be treated under the Lanham Act, and should remind trademark litigants and practitioners that issues involving monetary relief should be treated seriously, say attorneys at Finnegan.

  • New HSR Rules Augur A Deeper Antitrust Review By Agencies

    Author Photo

    After some initial uncertainty, the new Hart-Scott-Rodino Act rules did go into effect last month, and though their increased information requirements create greater initial burdens for merging parties, the rules should lead to greater certainty and predictability through a more efficient and effective review process, says Craig Malam at Edgeworth Economics.

  • 7 Tips For Associates To Thrive In Hybrid Work Environments

    Excerpt from Practical Guidance
    Author Photo

    As the vast majority of law firms have embraced some type of hybrid work policy, associates should consider a few strategies to get the most out of both their in-person and remote workdays, says James Argionis at Cozen O’Connor.

  • Series

    Playing Beach Volleyball Makes Me A Better Lawyer

    Author Photo

    My commitment to beach volleyball has become integral to my performance as an attorney, with the sport continually reminding me that teamwork, perseverance, professionalism and stress management are essential to both undertakings, says Amy Drushal at Trenam.

  • US Soccer Win Shows Value Of Defining 'Relevant Market'

    Author Photo

    Despite U.S. Soccer's successful defense against North American Soccer League's antitrust allegations, sports leagues should continue to be mindful of risks posed by hierarchical structures since the New York federal judge in that suit found a triable issue of fact on the relevant markets issue, say attorneys at Debevoise.

  • If Elphaba Had Signed A Restrictive Covenant In 'Wicked'

    Author Photo

    Following the recent big-screen release of "Wicked," employers should consider how the tale might have ended if the Wizard of Oz had made Elphaba sign a restrictive covenant agreement, which would have placed clear limitations on her ability to challenge his regime, says Emily Wajert at Sidley.

  • Opinion

    2 Errors Limit The Potential Influence Of AI Fair Use Case

    Author Photo

    The recent opinion in Thomson Reuters v. ROSS Intelligence may have little predictive value for artificial intelligence litigation, because the decision failed to engage with an important line of case law on intermediate copying, and misapplied the concepts of commercial substitution and superseding use, says Brandon Butler at Jaszi Butler PLLC.

  • How Law Firms Can Counteract The Loneliness Epidemic

    Author Photo

    The legal industry is facing an urgent epidemic of loneliness, affecting lawyer well-being, productivity, retention and profitability, and law firm leaders should take concrete steps to encourage the development of genuine workplace connections, says Michelle Gomez at Littler and Gwen Mellor Romans at Herald Talent.

  • Opinion

    DOJ's HPE-Juniper Challenge Is Not Rooted In Law

    Author Photo

    Legal precedents that date back as far as 1990 demonstrate that the U.S. Department of Justice's recent challenge to the proposed $14 billion merger between Hewlett Packard and Juniper is misplaced because no evidence of collusion or coordinated conduct exists, says Thomas Stratmann at George Mason University.

  • How Citizen Petitions Have Affected Drug Competition

    Author Photo

    In light of recent citizen petitions and proposed legislation regulating such petitions, Omar Robles at Managing Health analyzes the statistics of the extent to which citizen petitions have been filed, and to what extent they have delayed competition in prescription pharmaceuticals.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.